The Finnish startup, Meedoc, has announced a $1.5 million seed round funding from unnamed investors from the healthcare industry which spans the fields of pharma, doctors, care providers, and pharmacists.

Meedoc, which was co- founded by Mikko Kiiskilä is an app and service that lets patients connect with their doctor online via the medium of video. Telephone consultations are at present widely used by the medical industry especially for pre-screening and follow up consultations. However the medical community has been slow to upgrade the ‘technology’ in the age of mobile devices, applications and broadband.

Kiiskilä says that a startup hoping to make headway in the extremely regulated healthcare industry in Europe requires a different kind of investor profile, one that has the knowledge and connections to help with that mission. According to Kiiskilä, the mantra ‘move fast and break things’ doesn’t apply so much when you are dealing with people’s health.

Meedoc, which is currently slaunched in Finland, has successfully registered as a CE-certified Medical Device telemedicine platform, enabling it to be used for treatment across the European Union.

Perhaps the most noteworthy aspect of Meedoc’s simple app which enables on-demand or pre-booked video consultations with your doctor, is the startup’s target market, which is already seeing the service find favor with companies who want to make it part of their healthcare plan for employees.

The idea being that early medical attention in the form of a convenient video consultation can often result in less time off work and a healthier employee in general, specifically for simple and easily treatable conditions that don’t require a hands-on physical examination.

Doctors can also prescribe medication after a Meedoc-facilitated diagnosis. The employee doesn’t have to book time off work simply to see the doctor in the first place.

Meedoc charges companies €10 per month per employee for unlimited use. Kiiskilä says that the company counts thousands of patients as users ranging from SMEs to corporates.